180 related articles for article (PubMed ID: 7515443)
1. Design and synthesis of side-chain conformationally restricted phenylalanines and their use for structure-activity studies on tachykinin NK-1 receptor.
Josien H; Lavielle S; Brunissen A; Saffroy M; Torrens Y; Beaujouan JC; Glowinski J; Chassaing G
J Med Chem; 1994 May; 37(11):1586-601. PubMed ID: 7515443
[TBL] [Abstract][Full Text] [Related]
2. Tachykinin NK-1 receptor probed with constrained analogues of substance P.
Sagan S; Josien H; Karoyan P; Brunissen A; Chassaing G; Lavielle S
Bioorg Med Chem; 1996 Dec; 4(12):2167-78. PubMed ID: 9022979
[TBL] [Abstract][Full Text] [Related]
3. Topographic analysis of the S7 binding subsite of the tachykinin neurokinin-1 receptor.
Josien H; Convert O; Berlose JP; Sagan S; Brunissen A; Lavielle S; Chassaing G
Biopolymers; 1996 Aug; 39(2):133-47. PubMed ID: 8679946
[TBL] [Abstract][Full Text] [Related]
4. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
[TBL] [Abstract][Full Text] [Related]
5. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.
Ploux O; Lavielle S; Chassaing G; Julien S; Marquet A; d'Orléans-Juste P; Dion S; Regoli D; Beaujouan JC; Bergström L
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8095-9. PubMed ID: 2446317
[TBL] [Abstract][Full Text] [Related]
6. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
[TBL] [Abstract][Full Text] [Related]
7. Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues.
Lavielle S; Chassaing G; Brunissen A; Rodriguez M; Martinez J; Convert O; Carruette A; Garret C; Petitet F; Saffroy M
Int J Pept Protein Res; 1993 Sep; 42(3):270-7. PubMed ID: 7693605
[TBL] [Abstract][Full Text] [Related]
8. Calpha methylation in molecular recognition. Application to substance P and the two neurokinin-1 receptor binding sites.
Sagan S; Lequin O; Frank F; Convert O; Ayoub M; Lavielle S; Chassaing G
Eur J Biochem; 2001 May; 268(10):2997-3005. PubMed ID: 11358518
[TBL] [Abstract][Full Text] [Related]
9. Photoaffinity labeling the substance P receptor using a derivative of substance P containing p-benzoylphenylalanine.
Boyd ND; White CF; Cerpa R; Kaiser ET; Leeman SE
Biochemistry; 1991 Jan; 30(2):336-42. PubMed ID: 1703017
[TBL] [Abstract][Full Text] [Related]
10. [Pro9]SP and [pGlu6, Pro9]SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists.
Chassaing G; Lavielle S; Brunissen A; Carruette A; Garret C; Petitet F; Saffroy M; Beaujouan JC; Torrens Y; Glowinski J
Neuropeptides; 1992 Oct; 23(2):73-9. PubMed ID: 1280787
[TBL] [Abstract][Full Text] [Related]
11. Influence of the amino acids of substance P in the recognition of its receptor: affinities of synthesized SP analogues for the specific 125I-BHSP binding site on rat brain synaptosomes.
Lavielle S; Chassaing G; Julien S; Besseyre J; Marquet A
Neuropeptides; 1986; 7(2):191-200. PubMed ID: 2422581
[TBL] [Abstract][Full Text] [Related]
12. Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor.
Seelig A; Alt T; Lotz S; Hölzemann G
Biochemistry; 1996 Apr; 35(14):4365-74. PubMed ID: 8605185
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
[TBL] [Abstract][Full Text] [Related]
14. Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 1. Binding and pharmacological data.
Duplaa H; Chassaing G; Lavielle S; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; D'Orléans Juste P; Regoli D; Carruette A
Neuropeptides; 1991 Aug; 19(4):251-7. PubMed ID: 1717876
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
16. Binding sites for [3H][Sar9, Met(O2)11]substance P in rat brain and guinea pig ileum.
Tousignant C; Guillemette G; Regoli D
Brain Res; 1991 Sep; 560(1-2):1-11. PubMed ID: 1722129
[TBL] [Abstract][Full Text] [Related]
17. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P. Photoaffinity labeling and modeling studies.
Lequin O; Bolbach G; Frank F; Convert O; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
J Biol Chem; 2002 Jun; 277(25):22386-94. PubMed ID: 11950831
[TBL] [Abstract][Full Text] [Related]
19. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
20. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
